Resveratrol self-emulsifying system increases the uptake by endothelial cells and improves protection against oxidative stress-mediated death

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 86, Issue 3, 2014, Pages 418-426

  Amri, Ahmed ^a,b   Le Clanche, Solenn ^c   Thérond, Patrice ^c,d   Bonnefont Rousselot, Dominique ^c,e   Borderie, Didier ^c,f   Lai Kuen, René ^c   Chaumeil, Jean Claude ^a   Sfar, Souad ^b   Charrueau, Christine ^a  

^a UNIV PARIS SUD   (France)

^b UNIVERSITY OF MONASTIR   (Tunisia)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d BICÊTRE HOSPITAL   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f HÔTEL DIEU   (France)

Author keywords

Antioxidant; Atheroprotection; Endothelial cells; Nanoemulsion; Oxidative stress mediated death; Polyphenol

Indexed keywords

ALCOHOL; ANTIOXIDANT; HYDROGEN PEROXIDE; MIGLYOL; RESVERATROL; SURFACTANT; WATER; EMULSIFYING AGENT; STILBENE DERIVATIVE;

AGITATION; ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; BOVINE AORTIC ENDOTHELIAL CELL; CELL DEATH; CELL PROTECTION; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; EMULSION; ENDOTHELIUM CELL; FLUORESCENCE MICROSCOPY; IN VITRO STUDY; NANOEMULSION; NONHUMAN; OXIDATIVE STRESS; SELF EMULSIFYING DRUG DELIVERY SYSTEM; ZETA POTENTIAL; ANIMAL; BOVINAE; CELL CULTURE; CHEMISTRY; DRUG EFFECTS; METABOLISM; PHYSIOLOGY;

ANIMALS; CATTLE; CELL DEATH; CELLS, CULTURED; CYTOPROTECTION; EMULSIFYING AGENTS; ENDOTHELIAL CELLS; OXIDATIVE STRESS; STILBENES;

EID: 84898403075     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2013.10.015     Document Type: Article

References (54)

1. B.C. Vastano, Y. Chen, N. Zhu, C.T. Ho, Z. Zhou, and R.T. Rosen Isolation and identification of stilbenes in two varieties of Polygonum cuspidatum J. Agric. Food Chem. 48 2000 253 256
2. B.S. Gordon, D.C. Díaz, and M.C. Kostek Resveratrol decreases inflammation and increases utrophin gene expression in the mdx mouse model of duchenne muscular dystrophy Clin. Nutr. 32 2013 104 111
3. H.C. Su, L.M. Hung, and J.K. Chen Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats Am. J. Physiol. Endocrinol. Metab. 290 2006 1339 1346
4. M. Jang, L. Cai, G.O. Udeani, K.V. Slowing, C.F. Thomas, C.W. Beecher, H.H. Fong, N.R. Farnsworth, A.D. Kinghorn, R.G. Mehta, R.C. Moon, and J.M. Pezzuto Cancer chemopreventive activity of resveratrol, a natural product derived from grapes Science 275 1997 218 220
5. K.T. Howitz, K.J. Bitterman, H.Y. Cohen, D.W. Lamming, S. Lavu, J.G. Wood, R.E. Zipkin, P. Chung, A. Kisielewski, L.L. Zhang, B. Scherer, and D.A. Sinclair Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan Nature 425 2003 191 196
6. D.R. Valenzano, E. Terzibasi, T. Genade, A. Cattaneo, L. Domenici, and A. Cellerino Resveratrol prolongs lifespan and retards the onset of age-related markers in a shortlived vertebrate Curr. Biol. 16 2006 296 300
7. A.J. Baur, and D.A. Sinclair Therapeutic potential of resveratrol: the in vivo evidence Nat. Rev. 500 2006 493 506
8. S. Das, and D.K. Das Resveratrol: a therapeutic promise for cardiovascular diseases Recent Pat. Cardiovasc, Drug Discov. 2 2007 133 138
9. L.M. Hung, M.J. Su, and J.K. Chen Resveratrol protects myocardial ischemia-reperfusion injury through both NO-dependent and NO-independent mechanisms Free Radic. Biol. Med. 36 2004 774 781
10. M. Das, and D.K. Das Resveratrol and cardiovascular health Mol. Asp. Med. 31 2010 503 512
11. S.K. Nicholson, J.A. Tucker, and J.M. Brameld Effects of dietary polyphenols on gene expression in human vascular endothelial cells Proc. Nutr. Soc. 67 2008 42 47
12. I. Voloshyna, O. Hai, M.J. Littlefield, S. Carsons, and A.B. Reis Resveratrol mediates anti-atherogenic effects on cholesterol flux in human macrophages and endothelium via PPARg and adenosine Eur. J. Pharmacol. 698 2013 299 309
13. M.A. Markus, and B.J. Morris Resveratrol in prevention and treatment of common clinical conditions of aging Clin. Interv. Aging 3 2008 331 339
14. B. Hicham, G. Grenier, S. Loued, G. Drouin, and A. Khalil A new insight into resveratrol as an atheroprotective compound: inhibition of lipid peroxidation and enhancement of cholesterol efflux Atherosclerosis 207 2009 420 427
15. H.R. Superko Drug therapy and the prevention of atherosclerosis in humans Am. J. Cardiol. 64 1989 31G-8G
16. M. Frombaum, P. Thérond, R. Djelidi, J.L. Beaudeux, D. Bonnefont-Rousselot, and D. Borderie Piceatannol is more effective than resveratrol in restoring endothelial cell dimethylarginine dimethylaminohydrolase expression and activity after high-glucose oxidative stress Free Radic. Res. 45 2011 293 302
17. C.A. Schmitt, E.H. Heiss, and V.M. Dirsch Effect of resveratrol on endothelial cell function: molecular mechanism Biofactors 36 2010 342 349
18. A. Amri, J.C. Chaumeil, S. Sfar, and C. Charrueau Administration of resveratrol: what formulation solutions to bioavailability limitations? J. Control. Release 158 2012 182 193
19. C.W. Pouton Formulation of self-emulsifying drug delivery systems Adv. Drug Del. Rev. 25 1997 47 58
20. K. Kohli, S. Chopra, D. Dhar, S. Arora, and R.K. Khar Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability Drug Discov. Today 15 2010 21 22
21. L. Wei, P. Sun, S. Nie, and W. Pan Preparation and evaluation of SEDDS and SMEDDS containing carvedilol Drug Dev. Ind. Pharm. 31 2005 785 794
22. J. Hong, J. Kim, Y. Song, J. Park, and C.K. Kim A new self emulsifying formulation of itraconazole with improved dissolution and oral absorption J. Control. Release 110 2006 332 338
23. A. Arida, M.M. Al-Tabakha, and H.A. Hamoury Improving the high variable bioavailability of griseofulvin by SEDDS Chem. Pharm. Bull. 55 2007 1713 1719
24. S. Thomas, S. Kotamraju, J. Zielonka, D.R. Harder, and B. Kalyanaraman Hydrogen peroxide induces nitric oxide and proteosome activity in endothelial cells: a bell-shaped signaling response Free Radic. Biol. Med. 42 2007 1049 1061
25. R. Ross The pathogenesis of atherosclerosis: a perspective for the 1990s Nature 362 1993 1990 801 809
26. R.W. Alexander Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective Hypertension 25 1995 155 161
27. R. Ross The pathogenesis of atherosclerosis: an update N. Engl. J. Med. 314 1986 488 500
28. L. Camont, F. Collin, M. Couturier, P. Thérond, D. Jore, M. Gardès-Albert, and D. Bonnefont-Rousselot Radical-induced oxidation of trans-resveratrol Biochimie 94 2012 741 747
29. L.N. José Manuel, E. Núñez-Delicado, A.J. Pérez-López, A. Carbonell Barrachina, and P. Cuadra-Cresp Determination of stoichiometric coefficients and apparent formation constants for β-cyclodextrin complexes of trans-resveratrol using reversed-phase liquid chromatography J. Chromatogr. A. 1135 2006 158 165
30. D.Q.M. Craig, S.A. Barker, D. Banning, and S.W. Booth An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy Int. J. Pharm. 114 1995 103 110
31. M. Frombaum, S. Le Clanche, P. Thérond, E. Nubret, D. Bonnefont-Rousselot, and D. Borderie Penetration of resveratrol into bovine aortic endothelial cells (BAEC): a possible passive diffusion C. R. Biol. 335 2012 247 252
32. A. Lançon, D. Delmas, H. Osman, J.-P. Thénot, B. Jannin, and N. Latruffe Human hepatic cell uptake of resveratrol: involvement of both passive diffusion and carrier-mediated process Bioch. Biophys. Res. Commun. 316 2004 1132 1137
33. P. Balakrishnan, B.-J. Lee, D.H. Oh, J.O. Kim, M.J. Hong, J.P. Jee, J.A. Kim, B.K. Yoo, J.S. Woo, C.S. Yong, and H.-G. Choi Enhanced oral bioavailability of dexibuprofen by a novel solid self-emulsifying drug delivery system (SEDDS) Eur. J. Pharm. Biopharm. 72 2009 539 545
34. E. Atef, and A. Belmonte Formulation and in vitro and in vivo characterization of a phenytoin self-emulsifying drug delivery system (SEDDS) Eur. J. Pharm. Sci. 35 2008 257 263
35. 10 Eur. J. Pharm. Sci. 39 2010 224 232
36. 10 by self-emulsifying drug delivery systems Int. J. Pharm. 374 2009 66 72
37. 10 formulation development and bioavailability assessment Int. J. Pharm. 212 2001 233 246
38. G. Wakerly, C. Pouton, and B.J. Meakin Evaluation of the self-emulsifying performance of a non-ionic surfactant vegetable oil mixture J. Pharm. Pharmacol. 39 1987 6 14
39. D. Delmas, B. Jannin, and N. Latruffe Resveratrol: preventing properties against vascular alterations and ageing Mol. Nutr. Food Res. 49 2005 377 395
40. G.M. Do, E.Y. Kwon, H.J. Kim, S.M. Jeon, T.Y. Ha, T. Park, and M. Choi Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice Biochem. Biophys. Res. Commun. 374 2008 55 59
41. P.M. Brito, A. Mariano, L.M. Almeida, and T.C.P. Dinis Resveratrol affords protection against peroxynitrite-mediated endothelial cell death: a role for intracellular glutathione Chem. Biol. Interact. 164 2006 157 166
42. Z. Cao, and Y. Li Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: protection against oxidative and electrophilic injury Eur. J. Pharmacol. 489 2004 39 48
43. A. Movahed, L. Yu, S.J. Thandapilly, X.L. Louis, and T. Netticadan Resveratrol protects adult cardiomyocytes against oxidative stress mediated cell injury Arch. Biochem. Biophys. 527 2012 74 80
44. Y. Liu, F. Chan, H. Sun, J. Yan, D. Fan, D. Zhao, J. An, and D. Zhou Resveratrol protects human keratinocytes HaCaT cells from UVA-induced oxidative stress damage by downregulating Keap1 expression Eur. J. Pharm. 650 2011 130 137
45. J. Kristl, K. Teskac, C. Caddeo, Z. Abramovic, and M. Šentjurc Improvements of cellular stress response on resveratrol in liposomes Eur. J. Pharm. Biopharm. 73 2009 253 259
46. X. Lu, H. Xu, B. Sun, Z. Zhu, D. Zheng, and X. Li Enhanced neuroprotective effects of resveratrol delivered by nanoparticles on hydrogen peroxide-induced oxidative stress in rat cortical cell culture Mol. Pharm. 10 2013 2045 2053
47. S. Karthikeyan, N. Rajendra Prasad, A. Ganamani, and E. Balamurugan Anticancer activity of resveratrol-loaded gelatin nanoparticles on NCI-H460 non-small cell lung cancer cells Biomed. Prev. Nut. 3 2013 64 73
48. R.P. Joshi, G. Negi, A. Kumar, Y.B. Pawar, B. Munjal, A.K. Bansal, and S.S. Sharma SNEDDS curcumin formulation leads to enhanced protection from pain and functional deficits associated with diabetic neuropathy: an insight into its mechanism for neuroprotection Nanomedicine 9 2013 776 785
49. A.M. El-Mowafy, M. Alkhalaf, and S.M. Jaffal Nongenomic activation of the GC-A enzyme resveratrol and estradiol downstream from membrane estrogen receptors in human coronary arterial cells Nutr. Metab. Cardiovasc. 17 2007 508 516
50. G.H. Perdew, B.D. Hollingshead, B.C. DiNatale, J.L. Morales, M.P. Labrecque, M.K. Takhar, K.J. Tam, and T.V. Beischlag Estrogen receptor expression is required for low-dose resveratrol-mediated repression of aryl hydrocarbon receptor activity J. Pharmacol. Exp. Ther. 335 2010 273 283
51. R.N. Gursoy, and S. Benita Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs Biomed. Pharmacother. 58 2004 173 182
52. M.G. Wakerly, C.W. Pouton, B.J. Meakin, and F.S. Morton Self emulsification of vegetable oil-non-ionic surfactant mixtures ACS Symp. Ser. 311 1986 242 255
53. E.S. Swenson, W.B. Milisen, and W. Curatolo Intestinal permeability enhancement: efficacy, acute local toxicity and reversibility Pharm. Res. 11 1994 1132 1142
54. C. Maupas, B. Moulari, A. Béduneau, A. Lamprecht, and Y. Pellequer Surfactant dependent toxicity of lipid nanocapsules in HaCaT cells Int. J. Pharm. 411 2011 136-14